Global Infectious Disease Therapeutics Market 2019-2023

Global Infectious Disease Therapeutics Market 2019-2023

About this market

Development of novel drugs to drive growth in the market. There has been an increase in the R&D of novel drugs for the treatment of infectious diseases. Technavio’s analysts have predicted that the infectious disease therapeutics market will register a CAGR of over 4% by 2023.

Market Overview

Increasing prevalence of infectious diseases

There has been an increase in the prevalence of infectious diseases due to climate variability. This is expected to be a major driver of the market growth during the forecast period.

Availability of counterfeit drugs

Counterfeit drugs are available in low-income and developing countries. These drugs are widely available because of insufficient regulations and manufacturing control.

For the detailed list of factors that will drive and challenge the growth of the infectious disease therapeutics market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Merck and Sanofi the competitive environment is quite intense. Factors such as the development of novel drugs and the increase in the prevalence of infectious diseases, will provide considerable growth opportunities to infectious disease therapeutics manufactures. AbbVie, F. Hoffmann-La Roche, Gilead, Merck, and Sanofi are some of the major companies covered in this report.


PRESS RELEASE

Technavio Announces the Publication of its Research Report – Global Infectious Disease Therapeutics Market 2019-2023

Technavio recognizes the following companies as the key players in the global infectious disease therapeutics market: AbbVie, F. Hoffmann-La Roche, Gilead, Merck, and Sanofi.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the development of novel drugs.”

According to the report, one of the major drivers for this market is the increase in the prevalence of infectious diseases.

Companies Mentioned

AbbVie

F. Hoffmann-La Roche

Gilead

Merck

Sanofi

  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global pharmaceuticals market
      • Table Segments of global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline analysis
    • Table Phase III pipeline drugs for infectious diseases
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by type
    • Table Type - Market share 2018-2023 (%)
    • Comparison by type
      • Table Comparison by type
    • Antiviral - Market size and forecast 2018-2023
      • Table Antiviral - Market size and forecast 2018-2023 ($ millions)
      • Table Antiviral - Year-over-year growth 2019-2023 (%)
    • Antibacterial - Market size and forecast 2018-2023
      • Table Antibacterial - Market size and forecast 2018-2023 ($ millions)
      • Table Antibacterial - Year-over-year growth 2019-2023 (%)
    • Antifungal - Market size and forecast 2018-2023
      • Table Antifungal - Market size and forecast 2018-2023 ($ millions)
      • Table Antifungal - Year-over-year growth 2019-2023 (%)
    • Others - Market size and forecast 2018-2023
      • Table Others - Market size and forecast 2018-2023 ($ millions)
      • Table Others - Year-over-year growth 2019-2023 (%)
    • Market opportunity by type
      • Table Market opportunity by type
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • Americas - Market size and forecast 2018-2023
      • Table Americas - Market size and forecast 2018-2023 ($ millions)
      • Table Americas - Year-over-year growth 2019-2023 (%)
    • EMEA - Market size and forecast 2018-2023
      • Table EMEA - Market size and forecast 2018-2023 ($ millions)
      • Table EMEA - Year-over-year growth 2019-2023 (%)
    • APAC - Market size and forecast 2018-2023
      • Table APAC - Market size and forecast 2018-2023 ($ millions)
      • Table APAC - Year-over-year growth 2019-2023 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Pipeline drugs for infectious diseases
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • AbbVie
      • Table AbbVie - Vendor overview
      • Table AbbVie - Business segments
      • Table AbbVie - Organizational developments
      • Table AbbVie - Geographic focus
      • Table AbbVie - Key offerings
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche - Vendor overview
      • Table F. Hoffmann-La Roche - Business segments
      • Table F. Hoffmann-La Roche - Organizational developments
      • Table F. Hoffmann-La Roche - Geographic focus
      • Table F. Hoffmann-La Roche - Segment focus
      • Table F. Hoffmann-La Roche - Key offerings
    • Gilead
      • Table Gilead - Vendor overview
      • Table Gilead - Business segments
      • Table Gilead - Organizational developments
      • Table Gilead - Geographic focus
      • Table Gilead - Segment focus
      • Table Gilead - Key offerings
    • Merck
      • Table Merck - Vendor overview
      • Table Merck - Business segments
      • Table Merck - Organizational developments
      • Table Merck - Geographic focus
      • Table Merck - Segment focus
      • Table Merck - Key offerings
    • Sanofi
      • Table Sanofi - Vendor overview
      • Table Sanofi - Business segments
      • Table Sanofi - Organizational developments
      • Table Sanofi - Geographic focus
      • Table Sanofi - Segment focus
      • Table Sanofi - Key offerings
  • Appendix
    • Research methodology
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook